-
1
-
-
55849151593
-
-
CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006; Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA): London, 28 June
-
Guideline on the Limits of Genotoxic Impurities, CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006; Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA): London, 28 June 2006
-
(2006)
Guideline on the Limits of Genotoxic Impurities
-
-
-
2
-
-
77955404336
-
-
Committee for Medicinal Products for Human Use Safety Working Party(CHMP), European Medicines Agency (EMEA): London
-
Questions and answers on the CHMP guideline on the limits of genotoxic impurities,; Committee for Medicinal Products for Human Use Safety Working Party(CHMP), European Medicines Agency (EMEA): London 2008
-
(2008)
Questions and Answers on the CHMP Guideline on the Limits of Genotoxic Impurities
-
-
-
3
-
-
76749103090
-
-
Guidance for Industry (draft); U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville, MD.
-
Genotoxic and carcinogenic impurities in drug substances and drug products: Recommended approaches, Guidance for Industry (draft); U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville, MD, 2008; http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079235.pdf.
-
(2008)
Genotoxic and Carcinogenic Impurities in Drug Substances and Drug Products: Recommended Approaches
-
-
-
4
-
-
33645840463
-
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
-
Müller, L.; Mauthe, R. J.; Riley, C. M.; Andino, M. M.; Beels, C.; DeGeorge, J.; De Knaep, A. G. M.; Ellison, D.; Fagerland, J. A.; Frank, R.; Fritschel, B.; Galloway, S.; Harpur, E.; Humfrey, C. D. N.; Jack, A. S.; Jagota, N.; MacKinnon, J.; Mohan, G.; Ness, D.; O'Donovan, M. R.; Smith, M. D.; Vudathala, G. K.; Yotti, L. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity Reg. Toxicol. Pharmacol. 2006, 44, 198-211
-
(2006)
Reg. Toxicol. Pharmacol.
, vol.44
, pp. 198-211
-
-
Müller, L.1
Mauthe, R.J.2
Riley, C.M.3
Andino, M.M.4
Beels, C.5
Degeorge, J.6
De Knaep, A.G.M.7
Ellison, D.8
Fagerland, J.A.9
Frank, R.10
Fritschel, B.11
Galloway, S.12
Harpur, E.13
Humfrey, C.D.N.14
Jack, A.S.15
Jagota, N.16
MacKinnon, J.17
Mohan, G.18
Ness, D.19
O'Donovan, M.R.20
Smith, M.D.21
Vudathala, G.K.22
Yotti, L.23
more..
-
5
-
-
65949108606
-
Approaches to assessment testing decisions and analytical determination of genotoxic impurities in drug substances
-
Pierson, D. Approaches to assessment testing decisions and analytical determination of genotoxic impurities in drug substances Org. Process Res. Dev. 2009, 13 (2) 285-291
-
(2009)
Org. Process Res. Dev.
, vol.13
, Issue.2
, pp. 285-291
-
-
Pierson, D.1
-
6
-
-
77955363626
-
Genotoxic impurities: A case for regulatory rethink
-
FEB
-
Snodin, D.; Vudathala, G. K. Genotoxic impurities: A case for regulatory rethink AAPS Mag. 2009, Feb) 20-26
-
(2009)
AAPS Mag.
, pp. 20-26
-
-
Snodin, D.1
Vudathala, G.K.2
-
7
-
-
0033968631
-
First derivative spectroscopy and LC determination of benoxinate hydrochloride and its degradation Products
-
El-Grindy, A. First derivative spectroscopy and LC determination of benoxinate hydrochloride and its degradation Products J. Pharm. Biomed. Anal. 2000, 22, 215-234
-
(2000)
J. Pharm. Biomed. Anal.
, vol.22
, pp. 215-234
-
-
El-Grindy, A.1
-
8
-
-
33645866459
-
The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development
-
3, APRIL
-
Dobo, K. L.; Greene, N; Cyr, M. O.; Caron, S; Ku, W. W. The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development Regul. Toxicol. Pharmacol. 2006, 44 (3, April) 282-293
-
(2006)
Regul. Toxicol. Pharmacol.
, vol.44
, pp. 282-293
-
-
Dobo, K.L.1
Greene, N.2
Cyr, M.O.3
Caron, S.4
Ku, W.W.5
-
10
-
-
0037350199
-
-
Baker, M. T.; Gregroson, M. S.; Martin, S. M.; Buettner, G. R. Crit. Care Med. 2003, 31 (3) 787-792
-
(2003)
Crit. Care Med.
, vol.31
, Issue.3
, pp. 787-792
-
-
Baker, M.T.1
Gregroson, M.S.2
Martin, S.M.3
Buettner, G.R.4
-
11
-
-
49849084348
-
Structure alerts for carcinogenicity, and the Salmonella assay system: A novel insight through the chemical relational databases technology
-
3, SEP-OCT
-
Benigni, R.; Bossa, C. Structure alerts for carcinogenicity, and the Salmonella assay system: A novel insight through the chemical relational databases technology Mutat. Res. 2008, 659 (3, Sep-Oct) 248-261
-
(2008)
Mutat. Res.
, vol.659
, pp. 248-261
-
-
Benigni, R.1
Bossa, C.2
-
12
-
-
77955404263
-
-
http://www.inchem.org/documents/jecfa/jecmono/v52je14.htm.
-
-
-
-
13
-
-
50549101166
-
The FEMA GRAS assessment of α,β-unsaturated aldehydes and related substances used as flavor ingredients
-
9, SEP
-
Adams, T. B.; Gavin, C. L.; Taylor, S. V.; Waddell, W. J.; Cohen, S. M.; Feron, V. J.; Goodman, J.; Rietjens, I. M.; Marnett, L. J.; Portoghese, P. S.; Smith, R. L. The FEMA GRAS assessment of α,β-unsaturated aldehydes and related substances used as flavor ingredients Food Chem. Toxicol. 2008, 46 (9, Sep) 2935-2967
-
(2008)
Food Chem. Toxicol.
, vol.46
, pp. 2935-2967
-
-
Adams, T.B.1
Gavin, C.L.2
Taylor, S.V.3
Waddell, W.J.4
Cohen, S.M.5
Feron, V.J.6
Goodman, J.7
Rietjens, I.M.8
Marnett, L.J.9
Portoghese, P.S.10
Smith, R.L.11
-
14
-
-
77955355652
-
-
http://www.inchem.org/documents/jecfa/jecmono/v040je10.htm.
-
-
-
-
15
-
-
77955351849
-
-
http://www.inchem.org/documents/jecfa/jecmono/v040je11.htm.
-
-
-
-
16
-
-
77955366209
-
-
http://www.inchem.org/documents/jecfa/jecmono/v52je15.htm.
-
-
-
-
17
-
-
37349002009
-
Mechanistic QSAR of aromatic amines: New models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens
-
9, DEC
-
Benigni, R.; Bossa, C.; Netzeva, T.; Rodomonte, A.; Tsakovska, I. Mechanistic QSAR of aromatic amines: New models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens Environ. Mol. Mutagen. 2007, 48 (9, Dec) 754-771
-
(2007)
Environ. Mol. Mutagen.
, vol.48
, pp. 754-771
-
-
Benigni, R.1
Bossa, C.2
Netzeva, T.3
Rodomonte, A.4
Tsakovska, I.5
-
18
-
-
0035889635
-
Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part I. Alkylation ortho to the amino function
-
1-2, NOV 15
-
Glende, C.; Schmitt, H.; Erdinger, L.; Engelhardt, G.; Boche, G. Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part I. Alkylation ortho to the amino function Mutat. Res. 2001, 498 (1-2, Nov 15) 19-37
-
(2001)
Mutat. Res.
, vol.498
, pp. 19-37
-
-
Glende, C.1
Schmitt, H.2
Erdinger, L.3
Engelhardt, G.4
Boche, G.5
-
19
-
-
0037170698
-
Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part II: Alkylation far away from the amino function
-
1-2, MAR 25
-
Glende, C.; Klein, M.; Schmitt, H.; Erdinger, L.; Boche, G. Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part II: Alkylation far away from the amino function Mutat. Res. 2002, 515 (1-2, Mar 25) 15-38
-
(2002)
Mutat. Res.
, vol.515
, pp. 15-38
-
-
Glende, C.1
Klein, M.2
Schmitt, H.3
Erdinger, L.4
Boche, G.5
-
20
-
-
77955356382
-
-
http://dra4.nihs.go.jp/mhlw-data/home/file/file123-30-8.html.
-
-
-
-
21
-
-
77955390462
-
-
http://ntp.niehs.nih.gov/index.cfm?objectid=BD08DB0A-123F-7908- 7B82B481A44725F0.
-
-
-
|